PLAQUE CLAIMS ARE DRUG CLAIMS
This article was originally published in The Rose Sheet
PLAQUE CLAIMS ARE DRUG CLAIMS, FDA's OTC Plaque Subcommittee decided in a 4-2 vote Dec. 7. The recommendation voted on by the subcommittee states that in classifying OTC plaque products, "all references to the control of dental plaque, or its equivalents, with or without qualification, will be interpreted as a drug claim."
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review